CRINETICS PHARMACEUTICALS IN (CRNX) Stock Earnings Estimates

USA • Nasdaq • NASDAQ:CRNX • US22663K1079

47.61 USD
+1.6 (+3.48%)
At close: Feb 10, 2026
47.61 USD
0 (0%)
After Hours: 2/10/2026, 5:20:01 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
CRNX revenue by date.CRNX revenue by date.
4.74M
338.89%
4.013M
-15.34%
1.039M
-74.11%
6.225M
499.13%
61.823M
893.14%
214.45M
246.88%
551.01M
156.94%
1.214B
120.32%
2.163B
78.17%
3.398B
57.10%
4.897B
44.11%
7.023B
43.41%
EBITDA
YoY % growth
CRNX ebitda by date.CRNX ebitda by date.
-166.9M
-56.30%
-221.51M
-32.72%
-336.069M
-51.72%
-479.867M
-42.79%
-498.123M
-3.80%
-399.081M
19.88%
N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
CRNX ebit by date.CRNX ebit by date.
-167.88M
-55.88%
-222.608M
-32.60%
-338.854M
-52.22%
-533.783M
-57.53%
-568.562M
-6.52%
-425.156M
25.22%
-173.088M
59.29%
351.72M
303.20%
1.134B
222.42%
2.108B
85.89%
3.315B
57.26%
4.896B
47.69%
Operating Margin
CRNX operating margin by date.CRNX operating margin by date.
-3,541.77%-5,547.17%-32,613.47%-8,574.82%-919.66%-198.25%-31.41%28.97%52.43%62.04%67.69%69.71%
EPS
YoY % growth
CRNX eps by date.CRNX eps by date.
-3.14
-12.14%
-3.70
-17.83%
-3.71
-0.27%
-5.05
-36.07%
-5.15
-1.94%
-3.80
26.15%
-1.60
58.00%
2.73
271.25%
9.05
231.09%
14.90
64.65%
23.37
56.81%
40.43
73.02%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-1.40
-59.13%
-1.40
-34.27%
-1.38
-12.18%
-1.37
0.52%
-1.42
-1.66%
Revenue
Q2Q % growth
4.578M7.777M
2,054.29%
11.431M
1,008.73%
17.099M
11,857.34%
22.322M
387.59%
EBITDA
Q2Q % growth
-111.987M
-21.78%
-115.687M
-4.71%
-114.421M
10.07%
-121.372M
13.11%
N/A
EBIT
Q2Q % growth
-141.522M
-49.37%
-148.618M
-33.40%
-149.889M
-16.09%
-149.236M
-4.66%
-147.766M
-4.41%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-1.38
-43.75%
-1.28-0.10-7.76%
Q2 2025
Q2Q % growth
-1.23
-30.85%
-1.12-0.11-9.79%
Q1 2025
Q2Q % growth
-1.04
-11.83%
-0.96-0.08-8.34%
Q4 2024
Q2Q % growth
-0.88
2.22%
-0.910.032.94%
Q3 2024
Q2Q % growth
-0.96
4.95%
-0.93-0.03-3.35%
Q2 2024
Q2Q % growth
-0.94 -0.88-0.06-7.29%
Q1 2024
Q2Q % growth
-0.93
-9.41%
-0.83-0.10-12.64%
Q4 2023
Q2Q % growth
-0.90
-7.14%
-0.88-0.02-2.31%
Q3 2023
Q2Q % growth
-1.01
-29.49%
-0.88-0.13-15.29%
Q2 2023
Q2Q % growth
-0.94
-16.05%
-0.87-0.07-7.46%
Q1 2023
Q2Q % growth
-0.85
-19.72%
-0.83-0.02-2.64%
Q4 2022
Q2Q % growth
-0.84
-23.53%
-0.840.00-0.23%
Q3 2022
Q2Q % growth
-0.78
-6.85%
-0.850.078.05%
Q2 2022
Q2Q % growth
-0.81
-15.71%
-0.69-0.12-17.94%
Q1 2022
Q2Q % growth
-0.71
-2.90%
-0.59-0.12-20.01%
Q4 2021
Q2Q % growth
-0.68
-3.03%
-0.64-0.04-6.67%
Q3 2021
Q2Q % growth
-0.73
-30.36%
-0.730.000.04%
Q2 2021
Q2Q % growth
-0.70
-32.08%
-0.62-0.08-12.50%
Q1 2021
Q2Q % growth
-0.69
2.82%
-0.67-0.02-2.50%
Q4 2020
Q2Q % growth
-0.66 -0.59-0.07-11.95%
Q3 2020
Q2Q % growth
-0.56 -0.54-0.02-4.38%
Q2 2020
Q2Q % growth
-0.53 -0.580.058.20%
Q1 2020
Q2Q % growth
-0.71 -0.64-0.07-10.49%
CRNX Yearly EPS VS EstimatesCRNX Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 10 20 30 40
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
143K 370.892K-227.892K-61.44%
Q2 2025
Q2Q % growth
1.031M
158.40%
131.753K899.247K682.52%
Q1 2025
Q2Q % growth
361K
-43.59%
92.728K268.272K289.31%
Q4 2024
Q2Q % growth
738.113K-738.113K-100.00%
Q3 2024
Q2Q % growth

-100.00%
244.8K-244.8K-100.00%
Q2 2024
Q2Q % growth
399K
-59.62%
520.2K-121.2K-23.30%
Q1 2024
Q2Q % growth
640K
-76.11%
260.671K379.329K145.52%
Q4 2023
Q2Q % growth

-100.00%
265.2K-265.2K-100.00%
Q3 2023
Q2Q % growth
346K
-24.78%
125.97K220.03K174.67%
Q2 2023
Q2Q % growth
988K
124.55%
574.433K413.567K72.00%
Q1 2023
Q2Q % growth
2.679M
-14.41%
351.023K2.328M663.20%
Q4 2022
Q2Q % growth
710K
-34.26%
255K455K178.43%
Q3 2022
Q2Q % growth
460K 170.003K289.997K170.58%
Q2 2022
Q2Q % growth
440K 612K-172K-28.10%
Q1 2022
Q2Q % growth
3.13M 5.304M-2.174M-40.99%
Q1 2021
Q2Q % growth

-100.00%
%
CRNX Yearly Revenue VS EstimatesCRNX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2B 4B 6B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-1.05% -6.72% 1.23% -2.51%
Revenue22.54% 38.18% 14.03% 15.04%